Rezultati - Michael Grosso
- Showing 1 - 17 results of 17
-
1
-
2
Xanthine oxidase produces hydrogen peroxide which contributes to reperfusion injury of ischemic, isolated, perfused rat hearts. od Janet M. Brown, Lance S. Terada, Michael Grosso, G J Whitmann, Stephen E. Velasco, Antonia Patt, Alden H. Harken, John E. Repine
Izdano 1988Artigo -
3
Endotoxin pretreatment increases endogenous myocardial catalase activity and decreases ischemia-reperfusion injury of isolated rat hearts. od Janet M. Brown, Michael Grosso, Lance S. Terada, Gary J. Whitman, Anirban Banerjee, Carl W. White, Alden H. Harken, John E. Repine
Izdano 1989Artigo -
4
Single-dose ciraparantag safely and completely reverses anticoagulant effects of edoxaban od Jack Ansell, Sasha Bakhru, Bryan Laulicht, Solomon S. Steiner, Michael Grosso, Karen Brown, Victor Dishy, Hans Lanz, Michele Mercuri, Robert J. Noveck, James C. Costin
Izdano 2016Artigo -
5
-
6
Left atrial structure and function and the risk of death or heart failure in atrial fibrillation od Riccardo M. Inciardi, Robert P. Giugliano, Brian Claggett, Deepak K. Gupta, Alvin Chandra, Christian T. Ruff, Elliott M. Antman, Michele Mercuri, Michael Grosso, Eugene Braunwald, Scott D. Solomon
Izdano 2019Artigo -
7
Edoxaban Effects on Bleeding Following Punch Biopsy and Reversal by a 4-Factor Prothrombin Complex Concentrate od Hamim Zahir, Karen Brown, Alexander G. Vandell, Madhuri Desai, Jen‐Fue Maa, Victor Dishy, Barbara Lomeli, Annette Feussner, Wenqin Feng, Ling He, Michael Grosso, Hans Lanz, Elliott M. Antman
Izdano 2014Artigo -
8
Serial assessment of biomarkers and the risk of stroke or systemic embolism and bleeding in patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trial od Kazuma Oyama, Robert P. Giugliano, David D. Berg, Christian T. Ruff, Petr Jarolı́m, Minao Tang, Sabina A. Murphy, Hans Lanz, Michael Grosso, Elliott M. Antman, Eugene Braunwald, David A. Morrow
Izdano 2021Artigo -
9
Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism od Harry R. Büller, Hervé Decousus, Michael Grosso, Michele Mercuri, Saskia Middeldorp, Martin H. Prins, Gary E. Raskob, Sebastian Schellong, Lee Schwocho, Annelise Segers, Minggao Shi, Peter Verhamme, Philip S. Wells, Dominique Mottier
Izdano 2013Artigo -
10
Edoxaban Plus Aspirin vs Dual Antiplatelet Therapy in Endovascular Treatment of Patients With Peripheral Artery Disease: Results of the ePAD Trial od Frans L. Moll, Iris Baumgärtner, Michael R. Jaff, Chuke Nwachuku, Marco J.D. Tangelder, Gary M. Ansel, George L. Adams, Thomas Zeller, John H. Rundback, Michael Grosso, Min Lin, Michele F. Mercur, Erich Minar
Izdano 2018Artigo -
11
Treatment and outcomes after on-treatment recurrent venous thromboembolism in patients with cancer: a post-hoc analysis of the Hokusai VTE Cancer study od Vincent Lanting, Kika van Bergen en Henegouwen, Floris T.M. Bosch, Michael Grosso, Annelise Segers, Gary E. Raskob, T Pieter Willem Kamphuisen, Harry R. Büller, Peter Verhamme, Jeffrey I. Weitz, Marcello Di Nisio, Marc Carrier, Nick van Es, Tzu‐Fei Wang
Izdano 2025Artigo -
12
Clinical implications of incidental venous thromboembolism in cancer patients od Frits I. Mulder, Marcello Di Nisio, Cihan Ay, Marc Carrier, Floris T.M. Bosch, Annelise Segers, Noémie Kraaijpoel, Michael Grosso, George Zhang, Peter Verhamme, Tzu‐Fei Wang, Jeffrey I. Weitz, Saskia Middeldorp, Gary E. Raskob, Ludo F.M. Beenen, Harry R. Büller, Nick van Es
Izdano 2019Artigo -
13
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism od Gary E. Raskob, Nick van Es, Peter Verhamme, Marc Carrier, Marcello Di Nisio, David García, Michael Grosso, Ajay K. Kakkar, Michael J. Kovacs, Michele Mercuri, Guy Meyer, Annelise Segers, Minggao Shi, Tzu‐Fei Wang, Erik Yeo, George Zhang, Jeffrey I. Zwicker, Jeffrey I. Weitz, Harry R. Büller
Izdano 2017Artigo -
14
Recurrent venous thromboembolism and bleeding with extended anticoagulation: the VTE-PREDICT risk score od Maria A. de Winter, Harry R. Büller, Marc Carrier, Alexander T. Cohen, John‐Bjarne Hansen, Karin A. H. Kaasjager, Ajay K. Kakkar, Saskia Middeldorp, Gary E. Raskob, Henrik Toft Sørensen, Frank L.J. Visseren, Philip S. Wells, Jannick A N Dorresteijn, Mathilde Nijkeuter, Sigrid K. Brækkan, Louise Burggraaf, Suzanne C. Cannegieter, Alfredo E. Farjat, Ákos F. Pap, Samuel Z. Goldhaber, Michael Grosso, Erzsébet Horváth‐Puhó, Anthonie W.A. Lensing, Karen S. Pieper, Sam Schulman, Minggao Shi, Saverio Virdone
Izdano 2023Artigo -
15
Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism od Faizan Khan, Tobias Tritschler, Miriam Kimpton, Philip S. Wells, Clive Kearon, Jeffrey I. Weitz, Harry R. Büller, Gary E. Raskob, Walter Ageno, Françis Couturaud, Paolo Prandoni, Gualtiero Palareti, Cristina Legnani, Paul A. Kyrle, Sabine Eichinger, Lisbeth Eischer, Cecilia Becattini, Giancarlo Agnelli, Maria Cristina Vedovati, Geert‐Jan Geersing, Toshihiko Takada, Benilde Cosmi, Drahomir Aujesky, Letizia Marconi, Antonio Palla, Sergio Siragusa, Charlotte Bradbury, Sameer Parpia, Ranjeeta Mallick, Anthonie W.A. Lensing, Martin Gebel, Michael Grosso, Kednapa Thavorn, Brian Hutton, Grégoire Le Gal, Dean Fergusson, Marc Rodger
Izdano 2021Revisão -
16
Long‐term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and... od Faizan Khan, Tobias Tritschler, Miriam Kimpton, Philip S. Wells, Clive Kearon, Jeffrey I. Weitz, Harry R. Büller, Gary E. Raskob, Walter Ageno, Françis Couturaud, Paolo Prandoni, Gualtiero Palareti, Cristina Legnani, Paul A. Kyrle, Sabine Eichinger, Lisbeth Eischer, Cecilia Becattini, Giancarlo Agnelli, Maria Cristina Vedovati, Geert‐Jan Geersing, Toshihiko Takada, Benilde Cosmi, Drahomir Aujesky, Letizia Marconi, Antonio Palla, Sergio Siragusa, Charlotte Bradbury, Sameer Parpia, Ranjeeta Mallick, Anthonie W.A. Lensing, Martin Gebel, Michael Grosso, Minggao Shi, Kednapa Thavorn, Brian Hutton, Grégoire Le Gal, Marc Rodger, Dean Fergusson
Izdano 2021Revisão -
17
Edoxaban for Thromboembolism Prevention in Pediatric Patients With Cardiac Disease od Michael A. Portman, Jeffrey P. Jacobs, Jane W. Newburger, Felix Berger, Michael Grosso, Anil Duggal, Ben Tao, Neil A. Goldenberg, Matthew Brothers, Bradley S. Marino, Charles E. Canter, Mark E. Law, Nguyenvu Nguyen, Charlie J. Sang, Kristin Shimano, Dipankar Gupta, Michael A. Portman, Derek J. Williams, Lauren Glass, Charles Sperrazza, S. Herold, Ruchira Garg, Mark Vranicar, Sawsan Awad, Alfred Asante‐Korang, Colleen Druzgal, Caroline Ozment, Kamill Del Toro, Ferran Rosés‐Noguer, Christian Jux, Verena Gravenhorst, Ulrich Schweigmann, Mihir D. Bhatt, Christine Sabapathy, Nagib Dahdah, Dototea Bartonicek, Gerald Tulzer, Е. Н. Басаргина, T. N. Zvereva, Tatiana Pertels, I. N. Plotnikova, S.E.G.U.E.L.A. Pierre-Emmanuel, Pascal Amédro, Yves Dulac, Damien Bonnet, Paola Saraco, Alessandro Rimini, Valerii Digtiar, Margaryta Gonchar, Т.O. Kryuchko, Olga Yablon, Varinder Singh Bedi, Jashvant Patel, Monjori Mitra, Jacek Kusa, Kowalczyk Domagala, László KÖRNYEI, Csaba BERECZKI, László ABLONCZY, Vivianne Aviva Levitas, David Mishali, Shoshana Revel‐Vilk, Dan Harlev, Hatice Şaşmaz, Namık Yaşar Özbek, Şule Ünal, Türkan Patıroglu, Barış Malbora, Hasan Ağın, Zeynep Karakaş, Ramazan Kavakli, Elizabeth Chalmers, Frances Bu’Lock, Piers E.F. Daubeney, Hala Hamza, M.A. Badr, Mohsen Saleh Elalfy, Ahmed M. Mansour, Hoda Hassab, Ayman Sabry, Linda Daou, Fadi Bitar
Izdano 2022Artigo
Iskalna orodja:
Sorodne teme
Internal medicine
Medicine
Atrial fibrillation
Warfarin
Edoxaban
Thrombosis
Venous thromboembolism
Rivaroxaban
Cardiology
Anticoagulant
Chemistry
Intensive care medicine
Pharmacology
Adverse effect
Anesthesia
Biochemistry
Cancer
Cohort
Ischemia
Major bleeding
Oxidative stress
Pediatrics
Surgery
Catalase
Cohort study
Contractility
Cumulative incidence
Dabigatran
Endocrinology
Engineering